ACW.AX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 13:52):

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia...

Stats
今日成交量	6.16M
平均成交量	2.99M
市值	74.46M
EPS	$0 ( 2024-02-26 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.20
ATR14	$0 (0.00%)

Actinogen Medical Ltd 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Actinogen Medical Ltd 财务报表

Annual	2023
营收:	$4.89M
毛利润:	$4.48M (91.70 %)
EPS:	$-0.00570

FY	2023
营收:	$4.89M
毛利润:	$4.48M (91.70 %)
EPS:	$-0.00570

FY	2022
营收:	$3.64M
毛利润:	$3.24M (88.99 %)
EPS:	$-0.00530

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.00280

Financial Reports:

No articles found.

Actinogen Medical Ltd

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.